Glutamic acid decarboxylase (GAD) is the main target of humoral autoimmunity in patients with insulin-dependent diabetes mellitus (IDDM) and stiff-person syndrome. We reviewed the case of a 46-year-old woman who had cerebellar ataxia before getting stiff-person syndrome and IDDM with high anti-GAD autoantibody titers. This was a rare case in which there were both the clinical symptoms of stiff-person syndrome and cerebellar ataxia. In western blot analysis her serum reacted with 65-kDa proteins from rat cerebellum, cerebral cortex, and spinal cord. Autoantibodies to GAD may cause functional impairment of γ-aminobutyric acid (GABA) neurons in the spinal cord as well as in the cerebellum. © 2001, The Japanese Society of Internal Medicine. All rights reserved.
CITATION STYLE
Kono, S., Miyajima, H., Sugimoto, M., Suzuki, Y., Takahashi, Y., & Hishida, A. (2001). Stiff-person Syndrome Associated with Cerebellar Ataxia and High Glutamic Acid Decarboxylase Antibody Titer. Internal Medicine, 40(9), 968–971. https://doi.org/10.2169/internalmedicine.40.968
Mendeley helps you to discover research relevant for your work.